Alyeska Investment Group
HOWL icon

Alyeska Investment Group’s Werewolf Therapeutics HOWL Stock Holding History

Alyeska Investment Group’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$72.1K Sell
86,554
-149,151
-63% -$102K ﹤0.01% 604
2025
Q4 		$149K Hold
235,705
– – ﹤0.01% 575
2025
Q3 		$464K Hold
235,705
– – ﹤0.01% 562
2025
Q2 		$257K Hold
235,705
– – ﹤0.01% 536
2025
Q1 		$229K Hold
235,705
– – ﹤0.01% 485
2024
Q4 		$349K Hold
235,705
– – ﹤0.01% 529
2024
Q3 		$500K Hold
235,705
– – ﹤0.01% 486
2024
Q2 		$575K Hold
235,705
– – ﹤0.01% 495
2024
Q1 		$1.53M Sell
235,705
-200,000
-46% -$1.17M 0.01% 396
2023
Q4 		$1.68M Buy
435,705
+37,897
+10% +$96.8K 0.01% 382
2023
Q3 		$851K Hold
397,808
– – 0.01% 427
2023
Q2 		$1.21M Hold
397,808
– – 0.01% 443
2023
Q1 		$1.03M Buy
397,808
+191,607
+93% +$571K 0.01% 391
2022
Q4 		$423K Hold
206,201
– – ﹤0.01% 378
2022
Q3 		$930K Hold
206,201
– – 0.01% 344
2022
Q2 		$843K Hold
206,201
– – 0.01% 505
2022
Q1 		$907K Hold
206,201
– – 0.01% 527
2021
Q4 		$2.46M Hold
206,201
– – 0.03% 413
2021
Q3 		$3.54M Hold
206,201
– – 0.04% 394
2021
Q2 		$3.6M Buy
+206,201
New +$2.82M 0.04% 410

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alyeska Investment Group's HOWL Position: Q1 2026 in Review

Alyeska Investment Group reduced its Werewolf Therapeutics (HOWL) stake by 63% in Q1 2026, selling an estimated $102K and leaving 86,554 shares worth $72.1K. The position accounts for ﹤0.01% of the portfolio, ranked #604.

Alyeska Investment Group first reported a position in HOWL in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.6M in Q2 2021. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • Alyeska Investment Group held 86,554 shares of Werewolf Therapeutics worth $72.1K as of Q1 2026.
  • Alyeska Investment Group sold 149,151 Werewolf Therapeutics shares in Q1 2026, an estimated $102K.
  • Werewolf Therapeutics made up ﹤0.01% of Alyeska Investment Group's portfolio in Q1 2026, its #604 holding.
  • Alyeska Investment Group first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • Alyeska Investment Group's Werewolf Therapeutics position peaked at $3.6M in Q2 2021.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.